Case number 1:22-cv-00163
Acerta Pharma B.V. et al v. MSN Pharmaceuticals Inc., et al. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jul 12, 2022 | 30 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants MSN Pharmaceuticals Inc. and MSN Laboratories Pvt. Ltd.'s [CONFIDENTIAL] Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Phillips, John) |
| Jun 27, 2022 | 29 | Notice of Service (6) Docket Text: NOTICE OF SERVICE of Plaintiffs' Initial Disclosures Pursuant to paragraph 4(a) of the Delaware Default Standard for Discovery filed by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited, Merck Sharp & Dohme B.V..(Silver, Daniel) |
| Jun 22, 2022 | 28 | Certification for Jihad Komis (1) |
| Jun 22, 2022 | 28 | Main Document (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Jihad Komis - filed by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited, Merck Sharp & Dohme B.V.. (Attachments: # (1) Certification for Jihad Komis)(Joyce, Alexandra) |
| Jun 22, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (27 in 22-cv-155-RGA; 28 in 22-cv-163-RGA; 36 in 22-cv-154-RGA; 32 in 22-cv-164-RGA; 32 in 22-cv-162-RGA) MOTION for Pro Hac Vice Appearance of Attorney Jihad Komis, filed by Merck Sharp & Dohme B.V., AstraZeneca UK Limited, AstraZeneca Pharmaceuticals LP, AstraZeneca AB, Acerta Pharma B.V.. Signed by Judge Richard G. Andrews on 6/22/2022. Associated Cases: 1:22-cv-00154-RGA, 1:22-cv-00155-RGA, 1:22-cv-00162-RGA, 1:22-cv-00163-RGA, 1:22-cv-00164-RGA(nms) |
| Jun 3, 2022 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Bradford C. Frese for MSN Pharmaceuticals Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) |
| May 13, 2022 | 27 | Scheduling Order (13) Docket Text: SCHEDULING ORDER: Joinder of Parties due by 1/9/2023. Amended Pleadings due by 1/9/2023. Fact Discovery completed by 2/12/2024. Joint Claim Construction Brief due by 7/31/2023. A Markman Hearing is set for 8/31/2023, at 9:00 AM in Courtroom 6A. A Pretrial Conference is set for 2/21/2025, at 9:00 AM in Courtroom 6A. A 3 day Bench Trial on invalidity is set to start 3/3/2025, at 8:30 AM in Courtroom 6A. One day Bench Trials on infringement is set to start 3/10/2025, at 8:30 AM in Courtroom 6A (see Order for further details). Signed by Judge Richard G. Andrews on 5/13/2022. Associated Cases: 1:22-cv-00154-RGA, 1:22-cv-00155-RGA, 1:22-cv-00162-RGA, 1:22-cv-00163-RGA, 1:22-cv-00164-RGA(nms) |
| May 13, 2022 | 26 | Proposed Order (15) Docket Text: PROPOSED Scheduling Order, by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited, Merck Sharp & Dohme B.V.. (Joyce, Alexandra) Modified on 5/13/2022 (nms). |
| May 11, 2022 | N/A | Telephone Conference (0) Docket Text: Minute Entry for proceedings held before Judge Richard G. Andrews - Rule 16(b) Telephone Scheduling Conference held on 5/11/2022. Counsel for Plaintiffs: A. Joyce. Counsel for Defendants: D. Gattuso, M. Haney, M. Goeller. A 3-day Bench Trial on Invalidity is scheduled to begin on 3/3/2025. A Pretrial Conference is set for 2/21/2025, at 9:00 AM. Plaintiff's are directed to resubmit the proposed scheduling order reflecting the rulings the Court made during the hearing. (Court Reporter Heather Triozzi.) Associated Cases: 1:22-cv-00154-RGA, 1:22-cv-00155-RGA, 1:22-cv-00162-RGA, 1:22-cv-00163-RGA, 1:22-cv-00164-RGA(lak) |
| May 10, 2022 | 25 | Certification of Janine A. Carlan (1) |
| May 10, 2022 | 25 | Certification of Richard J. Berman (1) |
| May 10, 2022 | 25 | Main Document (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Richard J. Berman and Janine A. Carlan - filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc.. (Attachments: # (1) Certification of Richard J. Berman, # (2) Certification of Janine A. Carlan)(Haney, Megan) |
| May 10, 2022 | 24 | Motion for Leave to Appear Pro Hac Vice (4) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Alexander S. Zolan - filed by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited, Merck Sharp & Dohme B.V.. (Joyce, Alexandra) |
| May 10, 2022 | 23 | Certification of Brian H. Gold (1) |
| May 10, 2022 | 23 | Certification of Bradford C. Frese (1) |
| May 10, 2022 | 23 | Main Document (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Bradford C. Frese and Brian H. Gold - filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc.. (Attachments: # (1) Certification of Bradford C. Frese, # (2) Certification of Brian H. Gold)(Haney, Megan) |
| May 10, 2022 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Janine A. Carlan for MSN Pharmaceuticals Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) |
| May 10, 2022 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Brian H. Gold for MSN Pharmaceuticals Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) |
| May 10, 2022 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Alexander S. Zolan for Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited, and Merck Sharp & Dohme B.V. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) |
| May 10, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [25] MOTION for Pro Hac Vice Appearance of Attorney Richard J. Berman and Janine A. Carlan, filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc.. Signed by Judge Richard G. Andrews on 5/10/2022. (nms) |
| May 10, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (D.I. 24 in 22-cv-155-RGA; D.I. 28 in 22-cv-154-RGA; D.I. 29 in 22-cv-164-RGA; D.I. 29 in 22-cv-162-RGA; D.I. 24 in 22-cv-163-RGA) MOTION for Pro Hac Vice Appearance of Attorney Alexander S. Zolan, filed by Merck Sharp & Dohme B.V., AstraZeneca UK Limited, AstraZeneca Pharmaceuticals LP, AstraZeneca AB, Acerta Pharma B.V.. Signed by Judge Richard G. Andrews on 5/10/2022. Associated Cases: 1:22-cv-00154-RGA, 1:22-cv-00155-RGA, 1:22-cv-00162-RGA, 1:22-cv-00163-RGA, 1:22-cv-00164-RGA(nms) |
| May 10, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [23] MOTION for Pro Hac Vice Appearance of Attorney Bradford C. Frese and Brian H. Gold, filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc.. Signed by Judge Richard G. Andrews on 5/10/2022. (nms) |
| May 9, 2022 | 22 | Letter (1) Docket Text: Letter to The Honorable Richard G. Andrews from Alexandra M. Joyce, Esq. regarding Dial-In for Rule 16 Teleconference. (Joyce, Alexandra) |
| May 9, 2022 | 21 | Proposed Order (16) Docket Text: PROPOSED Scheduling Order, by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited, Merck Sharp & Dohme B.V.. (Joyce, Alexandra) Modified on 5/10/2022 (nms). |
| Apr 29, 2022 | 20 | Notice of Change of Address (2) Docket Text: NOTICE of Change of Address by Alexandra M. Joyce (Joyce, Alexandra) |
| Apr 28, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (D.I. 25 in 22-cv-162-RGA; D.I. 25 in 22-cv-164-RGA; D.I. 24 in 22-cv-154-RGA; D.I. 19 in 22-cv-163-RGA) STIPULATION and Proposed Order to Extend Time to Answer, Move, or Respond to the Counterclaims to May 16, 2022. Signed by Judge Richard G. Andrews on 4/28/2022. Associated Cases: 1:22-cv-00154-RGA, 1:22-cv-00162-RGA, 1:22-cv-00163-RGA, 1:22-cv-00164-RGA(nms) |
| Apr 28, 2022 | 19 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME the Deadline for Plaintiffs to Answer, Move, or Respond to the Counterclaims to May 16, 2022 - filed by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited, Merck Sharp & Dohme B.V.. (Joyce, Alexandra) |
| Apr 13, 2022 | 18 | Order Setting Scheduling Conference (1) Docket Text: Order Setting Rule 16(b) Telephone Conference: A Scheduling Conference is set for 5/11/2022, at 3:00 PM before Judge Richard G. Andrews (see Order for further details). Signed by Judge Richard G. Andrews on 4/13/2022. (nms) |
| Apr 11, 2022 | 16 | Answer to Amended Complaint (30) Docket Text: ANSWER to [15] Amended Complaint, and COUNTERCLAIMS against all Plaintiffs, by MSN Pharmaceuticals Inc., MSN Laboratories Private Limited.(Phillips, John) Modified on 4/11/2022 (nms). |
| Apr 11, 2022 | 17 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent MSN Laboratories Private Limited for MSN Pharmaceuticals Inc. filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc.. (Haney, Megan) |
| Mar 24, 2022 | 15 | Amended Complaint* (1) |
| Mar 24, 2022 | 15 | Exhibits A-F (608) |
| Mar 24, 2022 | 15 | Main Document (29) Docket Text: FIRST Amended Complaint against MSN Pharmaceuticals Inc. and MSN Laboratories Private Limited - filed by AstraZeneca AB, Acerta Pharma B.V., AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited, Merck Sharp & Dohme B.V.. (Attachments: # (1) Exhibits A-F)(Silver, Daniel) Modified on 3/25/2022 (nms). |
| Mar 24, 2022 | 14 | SO ORDERED (3) Docket Text: SO ORDERED, Granting [13] Stipulation and [Proposed] Order Regarding First Amended Complaint and Service of Process. Signed by Judge Richard G. Andrews on 3/24/2022. (nms) |
| Mar 24, 2022 | 13 | Stipulation (3) Docket Text: STIPULATION and [Proposed] Order Regarding First Amended Complaint and Service of Process by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited, Merck Sharp & Dohme B.V.. (Joyce, Alexandra) |
| Mar 2, 2022 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Kevin Hoagland-Hanson, Min Kyung Jeon, Stanley E. Fisher, David I. Berl, and Sarahi Uribe for Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited, Merck Sharp & Dohme B.V., added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:22-cv-00154-RGA, 1:22-cv-00155-RGA, 1:22-cv-00162-RGA, 1:22-cv-00163-RGA, 1:22-cv-00164-RGA(smg) |
| Feb 24, 2022 | 12 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME Defendant MSN Pharmaceuticals Inc.'s Deadline to Answer, Move or Otherwise Respond to the Complaint to April 11, 2022 - filed by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited, Merck Sharp & Dohme B.V.. (Silver, Daniel) |
| Feb 24, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [12] STIPULATION and Proposed Order to Extend Time to Answer, Move or Otherwise Respond to the Complaint(*Reset Answer Deadlines: MSN Pharmaceuticals Inc. answer due 4/11/2022). Signed by Judge Richard G. Andrews on 2/24/2022. (nms) |
| Feb 17, 2022 | 11 | Certifications for David I. Berl, Stanley E. Fisher, Kevin Hoagland-Hanson, Sar (5) |
| Feb 17, 2022 | 11 | Main Document (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney David I. Berl, Stanley E. Fisher, Kevin Hoagland-Hanson, Sarahi Uribe, and Min Kyung Jeon - filed by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited, Merck Sharp & Dohme B.V.. (Attachments: # (1) Certifications for David I. Berl, Stanley E. Fisher, Kevin Hoagland-Hanson, Sarahi Uribe, and Min Kyung Jeon)(Joyce, Alexandra) |
| Feb 17, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (12 in 22-cv-164-RGA; 11 in 22-cv-155-RGA; 11 in 22-cv-162-RGA; 11 in 22-cv-163-RGA; 11 in 22-cv-154-RGA) MOTION for Pro Hac Vice Appearance of Attorney David I. Berl, Stanley E. Fisher, Kevin Hoagland-Hanson, Sarahi Uribe, and Min Kyung Jeon, filed by Merck Sharp & Dohme B.V., AstraZeneca UK Limited, AstraZeneca Pharmaceuticals LP, AstraZeneca AB, Acerta Pharma B.V.. Signed by Judge Richard G. Andrews on 2/17/2022. Associated Cases: 1:22-cv-00154-RGA, 1:22-cv-00155-RGA, 1:22-cv-00162-RGA, 1:22-cv-00163-RGA, 1:22-cv-00164-RGA(nms) |
| Feb 9, 2022 | 10 | Exhibit A-B (7) |
| Feb 9, 2022 | 10 | Main Document (2) Docket Text: DECLARATION of Service of MSN Pharmaceuticals Inc., by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited, Merck Sharp & Dohme B.V.. (Attachments: # (1) Exhibits A-B)(Joyce, Alexandra) Modified on 2/9/2022 (nms). |
| Feb 9, 2022 | 9 | Exhibit A-B (7) |
| Feb 9, 2022 | 9 | Main Document (2) Docket Text: DECLARATION of Service of MSN Pharmaceuticals Inc., by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited, Merck Sharp & Dohme B.V.. (Attachments: # (1) Exhibits A-B)(Joyce, Alexandra) Modified on 2/9/2022 (nms). |
| Feb 9, 2022 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. Associated Cases: 1:22-cv-00154-RGA, 1:22-cv-00155-RGA, 1:22-cv-00162-RGA, 1:22-cv-00163-RGA, 1:22-cv-00164-RGA (rjb) |
| Feb 7, 2022 | 8 | Summons Issued (2) Docket Text: Summons Issued with Magistrate Consent Notice attached as to MSN Pharmaceuticals Inc. on 2/7/2022. (mal) |
| Feb 4, 2022 | 7 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Merck & Co., Inc. for Merck Sharp & Dohme B.V. filed by Merck Sharp & Dohme B.V.. (mal) |
| Feb 4, 2022 | 6 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent AstraZeneca PLC for Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals LP and AstraZeneca UK Limited filed by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals LP and AstraZeneca UK Limited. (mal) |
| Feb 4, 2022 | 5 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,272,083. (mal) |
| Feb 4, 2022 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,290,504 ;9,758,524 ;10,239,883 ;9,796,721 ;10,167,291. (mal) |
| Feb 4, 2022 | 3 | ANDA Form (2) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: No earlier than 12/28/2021. Date of Expiration of Patent: see attached.Thirty Month Stay Deadline: No earlier than 4/30/2025. (mal) |
| Feb 4, 2022 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mal) |
| Feb 4, 2022 | 1 | Civil Cover Sheet (2) |
| Feb 4, 2022 | 1 | Exhibit A-F (608) |
| Feb 4, 2022 | 1 | Complaint* (1) |
| Feb 4, 2022 | 1 | Main Document (27) Docket Text: COMPLAINT filed against MSN Pharmaceuticals Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3796390.) - filed by AstraZeneca AB, Acerta Pharma B.V., AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited, Merck Sharp & Dohme B.V.. (Attachments: # (1) Exhibit A-F, # (2) Civil Cover Sheet)(mal) |
